|
Market Closed -
Euronext Bruxelles
12:55:00 2026-10-27 EDT
|
After hours 16:59:31 | |||
| 16.34 EUR | +0.62% |
|
16.34 | 0.00% |
Business description: Ion Beam Applications, SA
- apparatuur en systemen voor diagnose en therapeutische behandeling (89,4%): apparatuur voor protontherapie (59,8% van de omzet; wereldwijd n° 1), deeltjesversnellers (40,2%) gebruikt voor de productie van radio-isotopen (cyclotrons) en voor de ontwikkeling van sterilisatie- en ionisatieoplossingen (Rhodotron®);
- dosimetrie-apparatuur en -oplossingen (10,6%; wereldwijd nr. 1): meet- en analyse-instrumenten voor de doses van straling en radiotherapie en medische beeldvorming.
De geografische verdeling van de omzet is als volgt: België (2,3%), Verenigde Staten (34%), China (11,6%), Duitsland (6,5%), India (5,8%) en andere (39,8%).
Number of employees: 2,264
Sales by Activity: Ion Beam Applications, SA
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Clinical Proton Therapy | - | - | - | - | 334M |
IBA Technologies | - | - | - | - | 225M |
IBA Clinical - Dosimetry | 52.33M | 53.97M | 65.91M | 65.88M | 65.69M |
Proton Therapy and Other Accelerators | 261M | 307M | 366M | 436M | - |
Eliminations | - | - | -3.62M | -4.09M | -4.72M |
Geographical breakdown of sales: Ion Beam Applications, SA
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Rest of World | 225M | 229M | 293M | 337M | 247M |
USA | 81.99M | 128M | 136M | 155M | 211M |
China | - | - | - | - | 71.95M |
Germany | - | - | - | - | 40.46M |
India | - | - | - | - | 36.21M |
Belgium | 5.67M | 4.25M | -243K | 5.25M | 14.01M |
Executive Committee: Ion Beam Applications, SA
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Legrain
CEO | Chief Executive Officer | 58 | 2012-04-30 |
Yves Jongen
CTO | Chief Tech/Sci/R&D Officer | 78 | 1986-03-27 |
Thomas Pevenage
DFI | Director of Finance/CFO | - | - |
Christian Matton
LAW | General Counsel | - | 2017-12-31 |
| Director of Finance/CFO | 55 | 2025-06-30 |
Composition of the Board of Directors: Ion Beam Applications, SA
| Director | Title | Age | Since |
|---|---|---|---|
Pierre Mottet
CHM | Chairman | 65 | 2013-04-30 |
Yves Jongen
BRD | Director/Board Member | 78 | 1991-04-30 |
Olivier Legrain
BRD | Director/Board Member | 58 | 2012-04-30 |
Marcel Miller
BRD | Director/Board Member | 73 | 2011-04-30 |
Hedvig Hricak
BRD | Director/Board Member | 79 | 2017-04-30 |
Christine Dubus
BRD | Director/Board Member | 62 | 2020-08-31 |
Richard Hausmann
BRD | Director/Board Member | 66 | 2020-08-31 |
Joyce Hansen
BRD | Director/Board Member | - | 2026-06-15 |
Stephen Hahn
BRD | Director/Board Member | - | 2026-06-15 |
Holdings: Ion Beam Applications, SA
| Name | Stocks | % | Valuation |
|---|---|---|---|
| 1,242,005 | 4.1% | 22 M $ |
Company details: Ion Beam Applications, SA
Ion Beam Applications SA
3, chemin du Cyclotron
1348, Louvain-la-Neuve
+32 1 047 58 11
http://www.iba-worldwide.com
Group companies: Ion Beam Applications, SA
| Name | Category and Sector |
|---|---|
IBA Dosimetry GmbH
 IBA Dosimetry GmbH Medical SpecialtiesHealth Technology Develops and manufactures medical equipment & provides software development services |
Medical Specialties
|
IBA Investments SCRL |
Other Advanced Medical Equipment & Technology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.62% | -0.97% | +47.74% | +84.22% | 528M | |
| +1.19% | +2.01% | +21.05% | +57.45% | 253B | |
| -0.42% | +3.37% | +4.03% | +19.79% | 164B | |
| -1.27% | +2.93% | -18.41% | +71.82% | 157B | |
| -1.14% | +0.02% | -55.43% | -9.48% | 66.06B | |
| -1.48% | -1.05% | +6.98% | +64.86% | 51.52B | |
| -0.99% | +2.05% | -15.47% | -9.20% | 52.64B | |
| +0.29% | +4.13% | +19.34% | +44.66% | 52.2B | |
| +0.87% | +4.47% | +19.90% | +70.16% | 49.61B | |
| +2.76% | +7.89% | +30.33% | +91.68% | 44.8B | |
| Average | +0.16% | +2.44% | +6.01% | +48.59% | 89.1B | |
| Weighted average by Cap. | +0.26% | +2.65% | +2.66% | +46.27% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IBAB Stock
- Company Ion Beam Applications, SA
Select your edition
All financial news and data tailored to specific country editions
